To interpret global changes in the serum proteome linked to NAC response/resistance in HER2-positive BC patients, the 43 and 54 proteins commonly identified by the three methods in the serum of responders and non-responders before NAC, respectively, were analyzed using the STRING software (see Figure 2). Here, ERBB2 is linked to breast cancer.